SGSM1 as a pan-cancer biomarker: multi-omics insights into immune regulation, prognostic value, and therapeutic implications
The findings demonstrated that SGSM1 could be used as a novel biological marker for a wide variety of tumor types. SGSM1 may be implicated in the tumor immune microenvironment, which holds promise as a putative novel treatment target for cancer.
Authors
- Dawei Liu (ORCID: https://orcid.org/0000-0003-1911-9207)
- Yang Luo (ORCID: https://orcid.org/0000-0002-0166-9027)
- Yufeng Liu (ORCID: https://orcid.org/0000-0002-9472-9104)
- Qing Li (ORCID: https://orcid.org/0000-0003-2652-6070)
- Tao Wang (ORCID: https://orcid.org/0000-0001-7087-4596)
- Lingfei Yan
- Dali Wu (ORCID: https://orcid.org/0000-0002-3117-7074)
- Guanghui Zhong
- Cuilian Li
Institutions
- Third Affiliated Hospital of Southern Medical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1007/s12672-025-02940-2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangdong Medical Research Foundation
- Southern Medical University